Erratum: Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction (Clinica Chimica Acta (2004) 346 (211-219) DOI: 10.1016/j.cccn.2004.03.036);Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction

Clinica Chimica Acta

Volumn 346, Issue 2, 2004, Pages 211-219

  Wu, Alan H B ^a   Smith, Andrew ^a   Christenson, Robert H ^b   Murakami, Maryann M ^c   Apple, Fred S ^c  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Acute myocardial infarction; Clinical sensitivity and specificity; Point of care testing

Indexed keywords

CREATINE KINASE; TROPONIN I;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; EMERGENCY WARD; EVALUATION; FEMALE; HEART INFARCTION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; ST SEGMENT ELEVATION;

EID: 3142608724     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2005.01.002     Document Type: Erratum

References (24)

1. Wu A.H.B., Apple F.S., Gibler W.B., Jesse R.L., Warshaw M.M., Valdes R. Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for use of cardiac markers in coronary artery diseases. Clin. Chem. 45:1999;1104-1121
2. Fesmire F.M., Decker W.W., Howell J.M., Kline J.A. Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected acute myocardial infarction or unstable angina. Ann. Emerg. Med. 35:2000;521-544
3. Joint European Society of Cardiology/American College of Cardiology Committee Myocardial infarction redefined - a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur. Heart J. 21:2000;1502-1513
4. Cannon C.P., Hand M.H., Bahr R., Boden W.E., Christenson R., Gibler W.B., et al. National Heart Attack Alert Program (NHAAP) Coordinating Committee Critical Pathways Writing Group. Critical pathways for management of patients with acute coronary syndromes: an assessment by the National Heart Attack Alert Program. Am. Heart J. 143:2002;777-789
5. Christenson R.H. Biochemical markers and the era of troponin. Maryl. Med. 2001;98-103. (Suppl.)
6. Apple F.S., Christenson R.H., Valdes R. Jr., Andriak A.J., Berg A., Duh S.H., et al. Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin gy the Triage Cardiac Panel for detection of myocardial infarction. Clin. Chem. 45:1999;199-205
7. Apple F.S., Anderson F.P., Collinson P., Jesse R.L., Kontos M.C., Levitt M.A., et al. Clinical evaluation of the First Medical whole blood point-of-care testing device for detection of myocardial infarction. Clin. Chem. 46:2000;1604-1609
8. Roberts W.L., Schwarz E.L., Ayanian S., Rifai N. Performance characteristics of a point of care C-reactive protein assay. Clin. Chim. Acta. 314:2001;255-259
9. Jaffe A.S., Ravkilde J., Roberts R., Naslund U., Apple F.S., Galvani M., et al. It's time for a change to a troponin standard. Circulation. 102:2000;1216-1220
10. Panteghini M., Pagani F., Yeo K.T.J., Apple F.S., Christenson R.H., Dati F., et al. Evaluation of the imprecision at low-range concentration of the assays for cardiac troponin determination. Clin. Chem. 50:2004;327-332
11. Apple F.S., Wu A.H.B. Myocardial infarction redefined: role of cardiac troponin testing. Chem. Chem. 47:2001;377-379
12. Apple F.S., Wu A.H.B., Jaffe A.S. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am. Heart J. 144:2002;981-986
13. Panteghini M., Gerhardt W., Apple F.S., Dati F., Ravkilde J., Wu A.H. Quality specifications for cardiac troponin assays. Clin. Chem. Lab. Med. 39:2001;174-178
14. Vaidya H.C., Maynard Y., Dietzler D.N., Ladenson J.H. Direct measurement of creatine kinase-MB activity in serum after extraction with a monoclonal antibody specific to the MB isoenzyme. Clin. Chem. 32:1986;657-663
15. Spencer C.A., Takeuchi M., Kazarosyan M. Current status and performance goals for serum thyrotropin (TSH) assays. Clin. Chem. 42:1996;140-145
16. Hafner G., Peetz D., Dati F., Post F., Blankenberg S., Peivandi A.A., et al. Analytical and clinical evaluation of troponin I determination on dimension RXL-HM. Clin. Chem. Lab. Med. 38:2000;355-361
17. Lee-Lewandrowski E., Corboy D., Lewandrowski K., Sinclair J., McDermot S., Benzer T.I. Implementation of a point-of-care satellite laboratory in the emergency department of an academic medical center. Impact on test turnaround time and patient emergency department length of stay. Arch. Pathol. Lab. Med. 127:2003;456-460
18. Caragher T.E., Fernandez B.B., Jacobs F.L., Barr L.A. Evaluation of quantitative cardiac biomarker point-of-care testing in the emergency department. J. Emerg. Med. 22:2002;1-7
19. Boden W.E., O'Rouke R.A., Crawford M.H., et al. for the Veteran Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) trial investigators. N. Engl. J. Med. 339:1998;1785-1792
20. Cannon C.P., et al. TACTICS-Thrombolysis in Myocardial Infarction-18 investigators Comparison of early invasive and concesrvative stategies in patients with unstable coronary syndromes treated with glycoprotein IIb/IIIa inhibitor tirofiban. N. Engl. J. Med. 344:2001;1879-1887
21. Dati F., Panteghini M., Apple F.S., Christenson R.H., Mair J., Wu A.H. Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): strategies and concepts on standardization of cardiac marker assays. Scan. J. Clin. Invest. 59:1999;113-123. [suppl.]
22. Morrow D.A., Cannon C.P., Rifai N., Frey M.J., Vicari R., Lakkis N., et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA. 286:2001;2405-2412
23. Apple F.S., Murakami M.M., Jesse R.L., Levitt M.A., Berger A.K., Pearce L.A., et al. Near-bedside whole-blood cardiac troponin I assay for risk assessment of patients with acute coronary syndromes. Clin. Chem. 48:2002;1874-1877
24. Agewall S. Evaluation of point-of-care test systems using the new definition of myocardial infarction. Clin. Biochem. 36:2003;27-30